June 14, 2021 8:26 AM

Beginning Monday, June 14, 2021, the MSU Veterinary Medical Center will allow clients into the building with patients. Find details here.

Any patient presented to the MSU Small Animal Emergency Service will undergo an initial medical evaluation to determine if urgent care is needed, and whether hospitalization is warranted. The MSU Small Animal Emergency Service will only hospitalize patients that our clinicians consider to be unstable or to have life-threatening conditions.

Contact Information

Email: komaromy@cvm.msu.edu

Phone: 517-353-5420

Fax: 517-355-5164

Veterinary Medical Center - South Building (Wings F - G)
784 Wilson RD, Room G383
East Lansing, MI 48824

Education

  • DrMedVet, University of Zurich, 1996
  • PhD, University of Florida, 2002
  • DACVO
  • DECVO

Research Interests

  • Inherited retinal diseases, therapies for retinal diseases
PubMed Research

Dr. András M. Komáromy joined the College as Associate Professor in January, 2012. The Komáromy lab works to determine the molecular causes of inherited retinal diseases in dogs and develop treatment approaches to ameliorate sight degeneration.

Dr. Komáromy and colleagues from the University of Pennsylvania School of Veterinary Medicine, Temple University, University of Florida, and Cornell University developed a gene therapy to treat achromatopsia—a model cone disease—in dogs. The truly ground-breaking treatment restored cone function and is now the foundation for new studies of retinal disease in humans. Funded by grants from the National Institutes of Health, his research focuses on a new gene therapy to recover diseased cones and their function.

He is a member of the ACVO Genetics Committee and served as chair from 2004 to 2009. He has published more than 50 articles and book chapters and has been an invited speaker at national and international conferences.

MSU Scholars

CVM Articles by András Komáromy

Eye-Eye Captain: Glaucoma, Uveal Cysts, and Cataract in an American Bulldog - January 04, 2021

Is Gene Therapy an Option for Glaucoma? - November 03, 2020